Contradiction keeps US policy at standstill on mitochondrial therapy
After a US scientific panel recommended trials of mitochondrial replacement therapy, Congress passed a legislative rider essentially forbidding it, according to a new article.
After a US scientific panel recommended trials of mitochondrial replacement therapy, Congress passed a legislative rider essentially forbidding it, according to a new article.
Leave a Reply